23 May 2019

Jeroen de Baaij, theme Renal disorders, was awarded with an Innovation Grant of the Dutch Kidney Foundation (Nierstichting). Jeroen's research proposal 'The HNF1B switch: Single-cell RNA sequencing to unravel renal cyst formation in ADTKD-HNF1B' was selected from a competitive field of innovative approaches to treat kidney disease.

Jeroen de Baaij

The project aims to understand renal cyst formation in patients with autosomal dominant tubulointerstitial kidney disease. This rare disease is caused by mutations in the HNF1B gene. Patients suffer from renal cysts, hypomagnesemia and diabetes. In the kidneys of these patients some cells form renal cysts, whereas other cells don’t. This project aims to decipher which mechanisms drive cells into cyst formation. By applying the innovative single-cell RNA-seq technique on renal cells, it will be possible to identify the mechanisms of renal cyst formation.
 
The Dutch Kidney Foundation aims to stimulate the quality of the renal scientific field in the Netherlands through providing grants that support innovation in the Netherlands. The program establishes stronger links between innovative research and patient care. By providing better understanding of cyst formation, the ultimate goal of improving treatment of patients with tubulointerstitial kidney disease may come one step closer.
 

Related news items


Lowering cholesterol is not enough to reduce hyperactivity of the immune system

14 June 2019

In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.

read more

A warm welcome for the new forces at RIMLS

13 June 2019

RIMLS is now on full strength by welcoming new colleagues. Let us introduce them to you and find out what they can do for you.

read more

New cause for vaginal yeast infections discovered

13 June 2019

Martin Jaeger, theme Infectious diseases and global health, and colleagues, identified SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Their findings were published in Science Translational Medicine.

read more

Internal KWF review procedure 2020

13 June 2019

In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

read more

A personal touch of Johan van der Vlag

13 June 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Johan van der Vlag.

read more

Peter van der Kraan new theme leader Inflammatory diseases

13 June 2019

It is our pleasure to introduce Peter van der Kraan from the Dept. of Rheumatology, as the new leader of our theme Inflammatory diseases. As such he will be the successor of Irma Joosten who has done an outstanding job in the last years as theme leader, for which we thank her wholeheartedly.

read more